BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 593188)

  • 1. [The clinical significance of the oxytocin challenge test (author's transl)].
    Matthies W; Kasper K; Krieg H
    Med Klin; 1977 Dec; 72(48):2059-62. PubMed ID: 593188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of various oxytocin challenge tests in monitoring pregnant women at risk (author's transl)].
    Bichler A; Dorfmann A
    Z Geburtshilfe Perinatol; 1975 Aug; 179(4):292-300. PubMed ID: 1179790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the oxytocin challenge test serve as the primary method for managing high-risk pregnancies?
    Hayden BL; Simpson JL; Ewing DE; Otterson WN
    Obstet Gynecol; 1975 Sep; 46(3):251-4. PubMed ID: 1161226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-negative oxytocin challenge test.
    Dittman R; Belcher J
    N Engl J Med; 1978 Jan; 298(1):56. PubMed ID: 618459
    [No Abstract]   [Full Text] [Related]  

  • 5. The oxytocin challenge test in the prognosis of high-risk labor.
    Sánchez-Ramos JE; Sandoval C; Llusiá JB
    Z Geburtshilfe Perinatol; 1976 Jun; 180(3):220-4. PubMed ID: 960963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relations between the oxytocin test and morphometry of the placenta].
    Sanchez-Ramos JE; Fabre E; Sandoval C; Botella-Llusia J
    J Gynecol Obstet Biol Reprod (Paris); 1976 Sep; 5(6):761-6. PubMed ID: 1026757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin challenge test as an out patient procedure.
    Sellappah S; Wagman H
    Br J Clin Pract; 1984; 38(7-8):255-8. PubMed ID: 6477800
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxytocin challenge test in monitoring high-risk pregnancies.
    Cooper JM; Soffronoff EC; Bolognese RJ
    Obstet Gynecol; 1975 Jan; 45(1):27-33. PubMed ID: 1110815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic tests of the placental efficiency (author's transl)].
    Muzyczuk Z; Czekanowski R
    Zentralbl Gynakol; 1977; 99(12):748-54. PubMed ID: 899355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of antepartal cardiotocogram in risk pregnancies--comparative evaluation of the non-stress test and oxytocin stress test].
    Quaas L; Siebers JW; Hillemanns HG
    Z Geburtshilfe Perinatol; 1985; 189(4):173-8. PubMed ID: 4049985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin challenge test in high-risk pregnancy.
    Farahani G; Vasudeva K; Petrie R; Fenton AN
    Obstet Gynecol; 1976 Feb; 47(2):159-68. PubMed ID: 1250537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antepartum assessment: the oxytocin challenge test and nonstressed heart rate testing.
    Chapman NL
    JOGN Nurs; 1976; 5(5 Suppl):74s-76s. PubMed ID: 1049296
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of the significance of positive oxytocin challenge test.
    Freeman RK; Goebelsman UW; Nochimson D; Cetrulo C
    Obstet Gynecol; 1976 Jan; 47(1):8-13. PubMed ID: 1246400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with the oxytocin challenge test. II. An ominous atypical pattern.
    Freeman RK; James J
    Obstet Gynecol; 1975 Sep; 46(3):255-9. PubMed ID: 1099496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal monitoring in EPH gestosis and idiopathic placentar insufficiency (author's transl)].
    Janisch H; Leodolter S; Müller-Tyl E; Reinold E; Spona J; Fröhlich H
    Z Geburtshilfe Perinatol; 1975 Jun; 179(3):169-78. PubMed ID: 1189512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a combination of non stress fetal heart rate monitoring and the oxytocin challenge test in high-risk pregnancies. The effects on perinatal mortality (author's transl)].
    Galvez-Hernandez E; Jimeno-Garcia JM; Novo-Dominguez A
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(1):51-6. PubMed ID: 7252089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The surveillance of pregnancies with suspected placental dysfunktion. I. Material and methods (author's transl)].
    Schmid J
    Z Geburtshilfe Perinatol; 1975 Dec; 179(6):420-4. PubMed ID: 1241201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dehydroepiandrosterone sulfate tolerance test in high-risk pregnancy as evaluation of feto-placental insufficiency].
    Goisis C; Goisis F; Grossi F
    Minerva Ginecol; 1977 May; 29(5):369-89. PubMed ID: 142931
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical application of the oxytocin challenge test.
    Ewing DE; Farina JR; Otterson WN
    Obstet Gynecol; 1974 Apr; 43(4):563-6. PubMed ID: 4817007
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antepartum oxytocin fetal assessment challenge test 1,827 case histories. Significance of "prepathological testing". "Results" (author's transl)].
    Novo-Dominguez A; Sandoval C; Botella-Llusia J
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(4):819-26. PubMed ID: 712044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.